Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome

Charles J. Glueck, Joel Pranikoff, Dawit Aregawi, Ping Wang

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Objective: To prospectively assess whether metformin diet safely provides primary and secondary prevention of gestational diabetes (GD). Design: Assess development of GD on metformin diet. Setting: Outpatient clinical research center. Patient(s): One hundred forty-two nondiabetic women with polycystic ovary syndrome (PCOS) who had at least one live-birth (LB) pregnancy on metformin diet (172 pregnancies, 180 LBs). Intervention(s): Women were given 26% protein, 44% carbohydrate diets, without calorie restriction during pregnancy. Metformin (2-2.55 g/d) was given preconception, through pregnancy. Main Outcome Measure(s): Development of GD. Result(s): On metformin, GD developed in 12 (7%) of 172 LB pregnancies. Forty-seven women had at least one previous LB pregnancy (n = 64) without metformin, with GD developing in 19 (30%). Subsequently, on metformin, these 47 women had 50 LB pregnancies, developing GD in 6 (12%), which was a statistically significant difference. Of 15 women who had previous GD without metformin, GD developed in 5 (31%) of 16 subsequent pregnancies on metformin. Of 32 women who were previously free of GD without metformin, GD developed in 1 (3%) of 34 subsequent pregnancies on metformin. Previous GD without metformin was the only statistically significant explanatory variable for current GD on metformin. Conclusion(s): Metformin diet during pregnancy in women with PCOS facilitates primary and secondary prevention of GD.

Original languageEnglish (US)
Pages (from-to)625-634
Number of pages10
JournalFertility and Sterility
Volume89
Issue number3
DOIs
StatePublished - Mar 1 2008

Fingerprint

Gestational Diabetes
Polycystic Ovary Syndrome
Metformin
Diet
Pregnancy
Live Birth
Primary Prevention
Secondary Prevention

All Science Journal Classification (ASJC) codes

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Glueck, Charles J. ; Pranikoff, Joel ; Aregawi, Dawit ; Wang, Ping. / Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome. In: Fertility and Sterility. 2008 ; Vol. 89, No. 3. pp. 625-634.
@article{7d5bc9e44af342e38f0734676f390c1e,
title = "Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome",
abstract = "Objective: To prospectively assess whether metformin diet safely provides primary and secondary prevention of gestational diabetes (GD). Design: Assess development of GD on metformin diet. Setting: Outpatient clinical research center. Patient(s): One hundred forty-two nondiabetic women with polycystic ovary syndrome (PCOS) who had at least one live-birth (LB) pregnancy on metformin diet (172 pregnancies, 180 LBs). Intervention(s): Women were given 26{\%} protein, 44{\%} carbohydrate diets, without calorie restriction during pregnancy. Metformin (2-2.55 g/d) was given preconception, through pregnancy. Main Outcome Measure(s): Development of GD. Result(s): On metformin, GD developed in 12 (7{\%}) of 172 LB pregnancies. Forty-seven women had at least one previous LB pregnancy (n = 64) without metformin, with GD developing in 19 (30{\%}). Subsequently, on metformin, these 47 women had 50 LB pregnancies, developing GD in 6 (12{\%}), which was a statistically significant difference. Of 15 women who had previous GD without metformin, GD developed in 5 (31{\%}) of 16 subsequent pregnancies on metformin. Of 32 women who were previously free of GD without metformin, GD developed in 1 (3{\%}) of 34 subsequent pregnancies on metformin. Previous GD without metformin was the only statistically significant explanatory variable for current GD on metformin. Conclusion(s): Metformin diet during pregnancy in women with PCOS facilitates primary and secondary prevention of GD.",
author = "Glueck, {Charles J.} and Joel Pranikoff and Dawit Aregawi and Ping Wang",
year = "2008",
month = "3",
day = "1",
doi = "10.1016/j.fertnstert.2007.03.036",
language = "English (US)",
volume = "89",
pages = "625--634",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "3",

}

Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome. / Glueck, Charles J.; Pranikoff, Joel; Aregawi, Dawit; Wang, Ping.

In: Fertility and Sterility, Vol. 89, No. 3, 01.03.2008, p. 625-634.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome

AU - Glueck, Charles J.

AU - Pranikoff, Joel

AU - Aregawi, Dawit

AU - Wang, Ping

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Objective: To prospectively assess whether metformin diet safely provides primary and secondary prevention of gestational diabetes (GD). Design: Assess development of GD on metformin diet. Setting: Outpatient clinical research center. Patient(s): One hundred forty-two nondiabetic women with polycystic ovary syndrome (PCOS) who had at least one live-birth (LB) pregnancy on metformin diet (172 pregnancies, 180 LBs). Intervention(s): Women were given 26% protein, 44% carbohydrate diets, without calorie restriction during pregnancy. Metformin (2-2.55 g/d) was given preconception, through pregnancy. Main Outcome Measure(s): Development of GD. Result(s): On metformin, GD developed in 12 (7%) of 172 LB pregnancies. Forty-seven women had at least one previous LB pregnancy (n = 64) without metformin, with GD developing in 19 (30%). Subsequently, on metformin, these 47 women had 50 LB pregnancies, developing GD in 6 (12%), which was a statistically significant difference. Of 15 women who had previous GD without metformin, GD developed in 5 (31%) of 16 subsequent pregnancies on metformin. Of 32 women who were previously free of GD without metformin, GD developed in 1 (3%) of 34 subsequent pregnancies on metformin. Previous GD without metformin was the only statistically significant explanatory variable for current GD on metformin. Conclusion(s): Metformin diet during pregnancy in women with PCOS facilitates primary and secondary prevention of GD.

AB - Objective: To prospectively assess whether metformin diet safely provides primary and secondary prevention of gestational diabetes (GD). Design: Assess development of GD on metformin diet. Setting: Outpatient clinical research center. Patient(s): One hundred forty-two nondiabetic women with polycystic ovary syndrome (PCOS) who had at least one live-birth (LB) pregnancy on metformin diet (172 pregnancies, 180 LBs). Intervention(s): Women were given 26% protein, 44% carbohydrate diets, without calorie restriction during pregnancy. Metformin (2-2.55 g/d) was given preconception, through pregnancy. Main Outcome Measure(s): Development of GD. Result(s): On metformin, GD developed in 12 (7%) of 172 LB pregnancies. Forty-seven women had at least one previous LB pregnancy (n = 64) without metformin, with GD developing in 19 (30%). Subsequently, on metformin, these 47 women had 50 LB pregnancies, developing GD in 6 (12%), which was a statistically significant difference. Of 15 women who had previous GD without metformin, GD developed in 5 (31%) of 16 subsequent pregnancies on metformin. Of 32 women who were previously free of GD without metformin, GD developed in 1 (3%) of 34 subsequent pregnancies on metformin. Previous GD without metformin was the only statistically significant explanatory variable for current GD on metformin. Conclusion(s): Metformin diet during pregnancy in women with PCOS facilitates primary and secondary prevention of GD.

UR - http://www.scopus.com/inward/record.url?scp=40349091404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40349091404&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2007.03.036

DO - 10.1016/j.fertnstert.2007.03.036

M3 - Article

C2 - 17678910

AN - SCOPUS:40349091404

VL - 89

SP - 625

EP - 634

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 3

ER -